{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:46:40Z","timestamp":1777078000012,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,24]]},"DOI":"10.7759\/cureus.107671","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:12:02Z","timestamp":1777075922000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of Comorbidity Burden With In-Hospital Mortality in Transcatheter Aortic Valve Replacement Patients With Coexisting Malignancy in the United States: A Retrospective Cohort Study"],"prefix":"10.7759","author":[{"given":"Teddy A","family":"Teddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spencer","family":"Cadet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fraol T","family":"Erega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelwahab","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Marzoung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia  O","family":"Okolie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendall","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000923","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto CM","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, et al.. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021, 143:e72-227. 10.1161\/CIR.0000000000000923","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.70121","article-title":"Clinical outcomes and prognostic implications of TAVR in patients with active cancer: a meta-analysis","volume":"48","author":"Saberian P","year":"2025","unstructured":"Saberian P, Contreras R, Gurram A, et al.. Clinical outcomes and prognostic implications of TAVR in patients with active cancer: a meta-analysis. Clin Cardiol. 2025, 48:e70121. 10.1002\/clc.70121","journal-title":"Clin Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.09.1095","article-title":"Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 2","volume":"70","author":"Chang HM","year":"2017","unstructured":"Chang HM, Okwuosa TM, Scarabelli T, Moudgil R, Yeh ET. Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 2. J Am Coll Cardiol. 2017, 70:2552-65. 10.1016\/j.jacc.2017.09.1095","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma JJ","year":"2019","unstructured":"Popma JJ, Deeb GM, Yakubov SJ, et al.. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019, 380:1706-15. 10.1056\/NEJMoa1816885","journal-title":"N Engl J Med"},{"key":"ref5","unstructured":"Healthcare cost and utilization project (HCUP). National Inpatient Sample (NIS) Database documentation. agency for healthcare research and quality. (2022). Accessed: March 28, 2026: https:\/\/hcup-us.ahrq.gov\/db\/nation\/nis\/nisdbdocumentation.jsp."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.08.1049","article-title":"A novel algorithm for treating chronic\u00a0total coronary artery occlusion","volume":"74","author":"Tanaka H","year":"2019","unstructured":"Tanaka H, Tsuchikane E, Muramatsu T, et al.. A novel algorithm for treating chronic\u00a0total coronary artery occlusion. J Am Coll Cardiol. 2019, 74:2392-404. 10.1016\/j.jacc.2019.08.1049","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.06.024","article-title":"Frailty in older adults undergoing aortic\u00a0valve replacement: the FRAILTY-AVR study","volume":"70","author":"Afilalo J","year":"2017","unstructured":"Afilalo J, Lauck S, Kim DH, et al.. Frailty in older adults undergoing aortic\u00a0valve replacement: the FRAILTY-AVR study. J Am Coll Cardiol. 2017, 70:689-700. 10.1016\/j.jacc.2017.06.024","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59497","article-title":"Racial and socioeconomic determinants of cardiovascular health: a comprehensive review","volume":"16","author":"Borkowski P","year":"2024","unstructured":"Borkowski P, Borkowska N, Mangeshkar S, Adal BH, Singh N. Racial and socioeconomic determinants of cardiovascular health: a comprehensive review. Cureus. 2024, 16:e59497. 10.7759\/cureus.59497","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s40959-024-00256-8","article-title":"Outcomes of patients with active cancer after transcatheter aortic valve replacement: an updated meta-analysis","volume":"10","author":"Felix N","year":"2024","unstructured":"Felix N, Nogueira A, Carvalho PE, et al.. Outcomes of patients with active cancer after transcatheter aortic valve replacement: an updated meta-analysis. Cardiooncology. 2024, 10:55. 10.1186\/s40959-024-00256-8","journal-title":"Cardiooncology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2024.101410","article-title":"Impact of cancer in patients with aortic stenosis undergoing transcatheter aortic valve replacement: A systematic review and meta-analysis","volume":"52","author":"Osawa T","year":"2024","unstructured":"Osawa T, Tajiri K, Hoshi T, Ieda M, Ishizu T. Impact of cancer in patients with aortic stenosis undergoing transcatheter aortic valve replacement: A systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2024, 52:101410. 10.1016\/j.ijcha.2024.101410","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivag001","article-title":"Transcatheter valve replacement in carcinoid heart disease: a\u00a0potential change of paradigm","volume":"41","author":"Barbier MA","year":"2026","unstructured":"Barbier MA, Gerard L, Grinberg D, Fran\u00e7ois L, Walter T, Obadia JF, Rioufol G. Transcatheter valve replacement in carcinoid heart disease: a\u00a0potential change of paradigm. Interdiscip Cardiovasc Thorac Surg. 2026, 41:ivag001. 10.1093\/icvts\/ivag001","journal-title":"Interdiscip Cardiovasc Thorac Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2019.87017","article-title":"Homogeneous group approach to Elixhauser comorbidity for hospital death using administrative data","volume":"16","author":"Chlebicki AZ","year":"2020","unstructured":"Chlebicki AZ, Kozio\u0142 M. Homogeneous group approach to Elixhauser comorbidity for hospital death using administrative data. Arch Med Sci. 2020, 16:321-36. 10.5114\/aoms.2019.87017","journal-title":"Arch Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e318297429c","article-title":"Why summary comorbidity measures such as the Charlson Comorbidity Index and Elixhauser Score work","volume":"53","author":"Austin SR","year":"2015","unstructured":"Austin SR, Wong YN, Uzzo RG, Beck JR, Egleston BL. Why summary comorbidity measures such as the Charlson Comorbidity Index and Elixhauser Score work. Med Care. 2015, 53:e65-72. 10.1097\/MLR.0b013e318297429c","journal-title":"Med Care"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000326","article-title":"A new Elixhauser-based comorbidity summary measure to predict in-hospital mortality","volume":"53","author":"Thompson NR","year":"2015","unstructured":"Thompson NR, Fan Y, Dalton JE, Jehi L, Rosenbaum BP, Vadera S, Griffith SD. A new Elixhauser-based comorbidity summary measure to predict in-hospital mortality. Med Care. 2015, 53:374-9. 10.1097\/MLR.0000000000000326","journal-title":"Med Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.102319","article-title":"Utilization and outcomes of structural heart disease interventions in patients with prior mediastinal radiation","volume":"4","author":"Ismayl M","year":"2025","unstructured":"Ismayl M, Ahmed H, Goldsweig AM, Herrmann J, Eleid MF, Rihal CS, Guerrero M. Utilization and outcomes of structural heart disease interventions in patients with prior mediastinal radiation. JACC Adv. 2025, 4:102319. 10.1016\/j.jacadv.2025.102319","journal-title":"JACC Adv"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd11060169","article-title":"Obesity and transcatheter aortic valve replacement","volume":"11","author":"Seo J","year":"2024","unstructured":"Seo J, Kharawala A, Borkowski P, et al.. Obesity and transcatheter aortic valve replacement. J Cardiovasc Dev Dis. 2024, 11:169. 10.3390\/jcdd11060169","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2018.10.026","article-title":"Transcatheter aortic valve replacement in oncology patients with severe aortic stenosis","volume":"12","author":"Landes U","year":"2019","unstructured":"Landes U, Iakobishvili Z, Vronsky D, et al.. Transcatheter aortic valve replacement in oncology patients with severe aortic stenosis. JACC Cardiovasc Interv. 2019, 12:78-86. 10.1016\/j.jcin.2018.10.026","journal-title":"JACC Cardiovasc Interv"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.030072","article-title":"Transcatheter aortic valve replacement in patients with or without active cancer","volume":"12","author":"Aikawa T","year":"2023","unstructured":"Aikawa T, Kuno T, Malik AH, et al.. Transcatheter aortic valve replacement in patients with or without active cancer. J Am Heart Assoc. 2023, 12:030072. 10.1161\/JAHA.123.030072","journal-title":"J Am Heart Assoc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-020-01539-5","article-title":"Ischaemic heart disease and cancer: competing malignant conditions","volume":"20","author":"Murphy AC","year":"2020","unstructured":"Murphy AC, Koshy AN, Yudi MB. Ischaemic heart disease and cancer: competing malignant conditions. BMC Cardiovasc Disord. 2020, 20:254. 10.1186\/s12872-020-01539-5","journal-title":"BMC Cardiovasc Disord"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2015.04.059","article-title":"Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level","volume":"65","author":"Barac A","year":"2015","unstructured":"Barac A, Murtagh G, Carver JR, et al.. Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level. J Am Coll Cardiol. 2015, 65:2739-46.","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.10.038","article-title":"Cardiovascular events among adults treated with chimeric antigen receptor T-cells (CAR-T)","volume":"74","author":"Alvi RM","year":"2019","unstructured":"Alvi RM, Frigault MJ, Fradley MG, et al.. Cardiovascular events among adults treated with chimeric antigen receptor T-cells (CAR-T). J Am Coll Cardiol. 2019, 74:3099-108. 10.1016\/j.jacc.2019.10.038","journal-title":"J Am Coll Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.09.054","article-title":"Femoral versus nonfemoral peripheral\u00a0access for transcatheter\u00a0aortic valve\u00a0replacement","volume":"74","author":"Beurtheret S","year":"2019","unstructured":"Beurtheret S, Karam N, Resseguier N, et al.. Femoral versus nonfemoral peripheral\u00a0access for transcatheter\u00a0aortic valve\u00a0replacement. J Am Coll Cardiol. 2019, 74:2728-39. 10.1016\/j.jacc.2019.09.054","journal-title":"J Am Coll Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2020.04.011","article-title":"Magnetic resonance imaging to detect\u00a0cardiovascular effects of cancer\u00a0therapy: JACC CardioOncology state-of-the-art review","volume":"2","author":"Harries I","year":"2020","unstructured":"Harries I, Liang K, Williams M, et al.. Magnetic resonance imaging to detect\u00a0cardiovascular effects of cancer\u00a0therapy: JACC CardioOncology state-of-the-art review. JACC CardioOncol. 2020, 2:270-92. 10.1016\/j.jaccao.2020.04.011","journal-title":"JACC CardioOncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v25i1.20","article-title":"The efficacy and safety of transcatheter aortic valve replacement in elderly patients with aortic stenosis","volume":"25","author":"An J","year":"2025","unstructured":"An J, Shi F, Wang H, Zhang H, Liu S. The efficacy and safety of transcatheter aortic valve replacement in elderly patients with aortic stenosis. Afr Health Sci. 2025, 25:248-58. 10.4314\/ahs.v25i1.20","journal-title":"Afr Health Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2023-002573","article-title":"Midterm outcomes of transcatheter aortic valve replacement in patients with active cancer","volume":"11","author":"Noguchi M","year":"2024","unstructured":"Noguchi M, Tabata M, Ito J, et al.. Midterm outcomes of transcatheter aortic valve replacement in patients with active cancer. Open Heart. 2024, 11:10.1136\/openhrt-2023-002573","journal-title":"Open Heart"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/480325-association-of-comorbidity-burden-with-in-hospital-mortality-in-transcatheter-aortic-valve-replacement-patients-with-coexisting-malignancy-in-the-united-states-a-retrospective-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:12:05Z","timestamp":1777075925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/480325-association-of-comorbidity-burden-with-in-hospital-mortality-in-transcatheter-aortic-valve-replacement-patients-with-coexisting-malignancy-in-the-united-states-a-retrospective-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.107671","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,24]]}}}